EMPLICITI
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0003-2291 -
Package NDC
0003-2291-11 -
Application number
BLA761035 -
SPL ID
8441efc2-338a-4d1d-8fa1-9b9863a49ffd -
SPL set ID
80686b7e-f6f4-4154-b5c0-c846425e2d91 -
UNII
1351PE5UGS -
RxCUI
1726110 -
RxCUI
1726115 -
RxCUI
1726117 -
RxCUI
1726119
What the source publishes
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Active ingredients
- elotuzumab
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "EMPLICITI",
"splId": "8441efc2-338a-4d1d-8fa1-9b9863a49ffd",
"labels": [
{
"setId": "80686b7e-f6f4-4154-b5c0-c846425e2d91",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80686b7e-f6f4-4154-b5c0-c846425e2d91",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=80686b7e-f6f4-4154-b5c0-c846425e2d91"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "E.R. Squibb & Sons, L.L.C.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, SINGLE-USE in 1 CARTON (0003-2291-11) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE",
"package_ndc": "0003-2291-11",
"identifierStatus": "well-formed",
"marketing_start_date": "20151130"
}
],
"productId": "0003-2291_8441efc2-338a-4d1d-8fa1-9b9863a49ffd",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"productNdc": "0003-2291",
"deaSchedule": null,
"genericName": "elotuzumab",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ELOTUZUMAB",
"strength": "300 mg/1"
}
],
"applicationNumber": "BLA761035",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20151130",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000192338",
"N0000192337",
"M0001357"
],
"upc": [
"0300032291118"
],
"unii": [
"1351PE5UGS"
],
"rxcui": [
"1726110",
"1726115",
"1726117",
"1726119"
],
"spl_set_id": [
"80686b7e-f6f4-4154-b5c0-c846425e2d91"
],
"pharm_class_cs": [
"Antibodies, Monoclonal [CS]"
],
"pharm_class_epc": [
"SLAMF7-directed Immunostimulatory Antibody [EPC]"
],
"pharm_class_moa": [
"SLAMF7-directed Antibody Interactions [MoA]"
],
"manufacturer_name": [
"E.R. Squibb & Sons, L.L.C."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0003-2291_8441efc2-338a-4d1d-8fa1-9b9863a49ffd"